Immatics NV (IMTX)
9.83
-0.09
(-0.91%)
USD |
NASDAQ |
Jan 16, 16:00
9.79
-0.04
(-0.41%)
After-Hours: 20:00
Immatics EPS Diluted (Quarterly): -0.4859 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| Evotec SE | -0.1417 |
| InflaRx NV | -0.2115 |
| BioNTech SE | -0.1395 |
| Anbio Biotechnology | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.06M |
| Revenue (Quarterly) | 6.061M |
| Total Expenses (Quarterly) | 65.13M |
| Enterprise Value | 707.98M |
| Profit Margin (Quarterly) | -974.4% |
| Earnings Yield | -11.13% |
| Normalized Earnings Yield | -12.09 |